FDA Scott Gottlieb testifies during a Senate hearing

The FDA Says It Will Likely Never Approve Smoking Cannabis

The federal agency joins a community of health experts who think smoking is not a good way to consume weed.

May 30, 2018 - Rob Hoffman

WASHINGTON, D.C. – APRIL 05: FDA Commissioner-designate Scott Gottlieb testifies during a Senate Health, Education, Labor and Pensions Committee hearing on April 5, 2017 on Capitol Hill in Washington, D.C. (Photo by Zach Gibson/Getty Images)

FDA Scott Gottlieb testifies during a Senate hearing

WASHINGTON, D.C. – APRIL 05: FDA Commissioner-designate Scott Gottlieb testifies during a Senate Health, Education, Labor and Pensions Committee hearing on April 5, 2017 on Capitol Hill in Washington, D.C. (Photo by Zach Gibson/Getty Images)

The commissioner of the Food and Drug Administration, Scott Gottlieb, recently suggested that the agency would never approve of smoking cannabis. This opposition to smoking is shared by many health experts, even those who approve of medical cannabis in general.

In Canada, which is slated to legalize cannabis for adult use this fall, physicians have also issued warnings about consuming cannabis by smoking it. One doctor called smoking “very archaic,” in an interview with the CBC. Others have said that smoking cannabis is dangerous for your lungs, and urged consumers to consider alternate methods of consumption such as oral extracts.

“Many of the chemicals found in tobacco smoke are also found in cannabis smoke,” reads Health Canada’s website.

In an interview with Bloomberg, Gottlieb likened smoking cannabis to crushing up a prescription pill and smoking it. Using the lungs as an entry point for a drug, said Gottlieb, “isn’t optimal.”

This opinion has been reflected in some state laws, too, where cannabis flower has been legalized for medical purposes yet patients are not technically allowed to smoke it. While unenforceable, these laws are intended to encourage vaping instead.

FDA says it probably will never advocate smoking weed1 Lawmakers Heavily Disagree On Recreational Cannabis Legalization In New York State
Scott Gottlieb, the commissioner of the FDA, speaking at The Wall Street Journal Health Forum in Washington, DC on May 22, 2018.

The statement by the FDA commissioner does not mean the FDA won’t be approving the consumption of cannabis, in general, in the future. It’s becoming increasingly difficult for the federal agency to deny the medical potential of cannabis.

Recently, a panel of outside advisers to the FDA unanimously agreed that the benefits of a drug made by GW Pharmaceuticals, which uses the cannabis compound cannabidiol (CBD), outweighed its risks when treating forms of rare childhood epilepsy.

CBD, particularly as a treatment for epileptic seizures, is one of the most commonly accepted forms of medical cannabis. Last year, the United Nation’s World Health Organization released a report that concluded that CBD could have “therapeutic value” and “exhibits no effects indicative of any abuse or dependence potential.”

The FDA will likely decide on whether to approve GW Pharmaceuticals’ new CBD-based drug for public use by the end of June. If the drug, called Epidiolex, is approved, it will become the first ever FDA-sanctioned cannabis-derived medication in the country. 

Share This

Related Articles

Families with epileptic children don’t want to swap what’s already working for this new med.

Meagan Patrick plays with her daughter, Addie, at their Acton home Wednesday, Dec. 4, 2013. Addie suffers from severe epilepsy, and research shows that medical marijuana can help cut down on the number of seizures the children have. Patrick is so desperate to try it for Addie, she is flying to Colorado later this month - a state that is at the forefront of research for pediatric uses of medicinal marijuana - to establish legal residency there. (Photo by Gabe Souza/Portland Press Herald via Getty Images)

This would transform the booming CBD market.

Colombian Ines Cano gives medical marijuana to her daughter Luna Valentina (L) at their home in Medellin, Antioquia department, Colombia on November 25, 2015. Valentina, 12, who was born with refractory epilepsy, started to use medical marijuana as an alternative medicine, which is the only solution which calms her seizures. Medical marijuana, or CBD more specifically, has shown promise in children with epilepsy.

Federal laws have to change so Epidiolex can get to market. Will it impact other CBD products?

UNITED STATES - JUNE 04: Director of the DEA Chuck Rosenberg, then a US Attorney General of the Eastern District of Virginia, speaking at a news conference at the Department of Justice in Washington, D.C., June 4, 2007. Experts remain uncertain about whether the DEA will reclassify Epidiolex or CBD itself following FDA approval of Epidiolex for epilepsy on Monday, June 25. (Photo by Chris Kleponis/Bloomberg via Getty Images)


Stay in the loop

Exclusive deals, original content.
Delivered to you.